Lilly completes Phase 1 PK study of LY4268989 (MORF-057) in healthy volunteersNov 16Trial updateEli Lillyzotemtegrast
Lilly advances obesity and inflammation pipeline with new Phase 1 trials, Phase 2 updatesOct 9Weekly roundup, 10 itemsEli Lillyeloralintide
Lilly posts results for five completed Phase 1 studies, opens three new early trialsJul 17Weekly roundup, 8 itemsEli Lillyeloralintide